Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

HORIBA Businesses Invest in R&D Site, Acquire MedTest Holdings

Facebook Twitter LinkedIn Email
HORIBA FRANCE SAS, a developer of Raman spectroscopy systems and technology, inaugurated a new site in Loos, France. The facility replaces the company’s former location in Villeneuve d’Ascq. In a press release, HORIBA said the production and R&D site will enable the company to meet the increasing demand for Raman spectroscopy.

The new building will increase manufacturing capacity by 30%, HORIBA said, and will be a technological showcase for all of HORIBA’s present and future customers. The site, with a surface area of 6764 sq m on a 14,500-sq-m parcel, includes R&D and applications laboratories, large production areas (mechanical, optical, electronic), and sales and customer support areas.

HORIBA said its new R&D and production facility will ncrease manufacturing capacity by 30%. Courtesy of HORIBA FRANCE SAS.
HORIBA said its new R&D and production facility will increase manufacturing capacity by 30%. Courtesy of HORIBA FRANCE SAS.

In a separate move, HORIBA Ltd. and HORIBA Instruments acquired MedTest Holdings Inc., a provider of clinical testing solutions with open channel reagents for chemistry, drugs of abuse, and toxicology testing solutions. MedTest Holdings is composed of MedTest Dx Inc., Pointe Scientific Inc., Clintox Diagnostics Inc., and Medical Laboratory Solutions Inc. HORIBA said that the acquisition will combine the complementary innovative technology offerings of the HORIBA Medical segment (HORIBA Medical) with MedTest Dx technology, Clinitox, and Pointe Scientific’s R&D and manufacturing capabilities, and expand HORIBA’s laboratory chemistry offerings.

May/Jun 2021
raman spectroscopy
That branch of spectroscopy concerned with Raman spectra and used to provide a means of studying pure rotational, pure vibrational and rotation-vibration energy changes in the ground level of molecules. Raman spectroscopy is dependent on the collision of incident light quanta with the molecule, inducing the molecule to undergo the change.
BiophotonicsmedicalchemistryBusinesseducationspectroscopyRaman spectroscopyacquisitionsnew facilityR&DHoribaHoriba InstrumentsHoriba Medicalinstrumentationlight speedBioScan

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2023 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.